Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.
Saved in:
| Title: | Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences. |
|---|---|
| Authors: | Arango C; Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, Universidad Complutense, School of Medicine, Madrid, Spain., Baeza I; Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain; Fundació de Recerca Clínic Barcelona-Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM; Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain., García-Rizo C; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona Spain; Centro de Investigación Biomédica en red de salud Mental (CIBERSAM), Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Medicine Department, Barcelona, Spain., Crespo-Facorro B; Hospital Universitario Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Sevilla, Spain; Centro Investigación Biomédica en Red Salud Mental, CIBERSAM, Madrid, Spain; Instituto de Biomedicina de Sevilla (IBiS), HUVR/CSIC/Universidad de Sevilla, Seville, Spain; Department of Psychiatry, Universidad de Sevilla, Seville, Spain., Lahera G; Faculty of Medicine and Health Sciences, University of Alcalá, Madrid, Spain; CIBERSAM, Ramón y Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain; Principe de Asturias University Hospital, Alcalá, Spain., Vieta E; Department of Psychiatry and Psychology, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain., Becker F; Putnam Associates, Fitzrovia, London, England., Dwyer G; Putnam Associates, Fitzrovia, London, England., Bourke S; Putnam Associates, Fitzrovia, London, England., Gibson AEJ; Putnam Associates, Fitzrovia, London, England., Gabarda-Inat I; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain., Alvarez-Baron E; Angelini Pharma España S.L.U. Global Medical Department, Barcelona, Spain. |
| Source: | Patient preference and adherence [Patient Prefer Adherence] 2025 Aug 27; Vol. 19, pp. 2647-2661. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475748 Publication Model: eCollection Cited Medium: Print ISSN: 1177-889X (Print) Linking ISSN: 1177889X NLM ISO Abbreviation: Patient Prefer Adherence Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1177-889X |
|---|---|
| DOI: | 10.2147/PPA.S494721 |
